Technical Analysis for CNCR - Loncar Cancer Immunotherapy ETF

Grade Last Price % Change Price Change
C 14.81 -0.67% -0.10
CNCR closed down 0.67 percent on Thursday, January 26, 2023, on 1.52 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up

Date Alert Name Type % Chg
Stochastic Sell Signal Bearish 0.00%
Outside Day Range Expansion 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Overbought Stochastic Strength -0.67%
Gapped Down Weakness -0.67%
Pocket Pivot Bullish Swing Setup -1.13%
Overbought Stochastic Strength -1.13%
Up 3 Days in a Row Strength -1.13%
NR7 Range Contraction 0.47%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Support about 19 hours ago
Rose Above Previous Day's High about 21 hours ago
Outside Day about 21 hours ago
Fell Below Previous Day's Low about 21 hours ago
Down 1% about 21 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Loncar Cancer Immunotherapy ETF Description

ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.


Classification

Keywords: Exchange Traded Fund ETF Exchange Traded Funds Biotechnology SPDR Cancer Betashares Immune System Immunotherapy Cancer Immunotherapy Lonca Biotechnology Sectors Loncar Cancer Immunotherapy Index

Top 10 Components

Symbol Grade Price % Change Allocation
JANX A -1.14 5.41
RAPT B 0.33 5.19
BGNE C 0.12 4.17
IGMS C -0.41 4.13
IOVA D 8.32 3.92
XNCR B 1.07 3.76
MRUS F -1.36 3.72
ALLO F 7.15 3.65
CRSP D 1.17 3.56
REPL C -0.08 3.47
View All CNCR Holdings

Is CNCR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 19.76
52 Week Low 12.76
Average Volume 3,586
200-Day Moving Average 15.19
50-Day Moving Average 14.46
20-Day Moving Average 14.20
10-Day Moving Average 14.71
Average True Range 0.32
RSI 57.98
ADX 16.99
+DI 39.18
-DI 21.98
Chandelier Exit (Long, 3 ATRs) 14.18
Chandelier Exit (Short, 3 ATRs) 14.05
Upper Bollinger Bands 15.30
Lower Bollinger Band 13.09
Percent B (%b) 0.78
BandWidth 15.56
MACD Line 0.17
MACD Signal Line 0.05
MACD Histogram 0.1105
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.56
Resistance 3 (R3) 15.59 15.37 15.43
Resistance 2 (R2) 15.37 15.18 15.35 15.39
Resistance 1 (R1) 15.09 15.06 14.98 15.06 15.35
Pivot Point 14.87 14.87 14.82 14.86 14.87
Support 1 (S1) 14.59 14.68 14.48 14.56 14.27
Support 2 (S2) 14.37 14.56 14.36 14.23
Support 3 (S3) 14.09 14.37 14.19
Support 4 (S4) 14.06